Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals a 27.3% cesarean rate in first-time mothers, highlighting fetal distress and emergency procedures as leading drivers.
Aims: This retrospective cohort study evaluated cesarean section (CS) rates and indications among primigravid women at the Queen Elizabeth Hospital (QEH) between August 2022 and August 2024. Singleton pregnancies beyond 28 weeks’ gestation were included. Of 1273 primigravid patients, 348 underwent CS, giving a rate of 27.3%. The leading indications were fetal distress (32.6%), failed induction or augmentation of labor (21.3%), and eclampsia/preeclampsia (7.8%). Most CS procedures were emergencies (90.8%), while 9.2% were elective. Most patients were aged 21–29 years and had full-term pregnancies. Continued audits are recommended to evaluate indications and reduce unnecessary CS deliveries. The aims of this study were to determine the rate and indications for cesarean section (CS) deliveries among primigravid women and to analyze trends in the indications for cesarean sections performed at the QEH. Methods: A retrospective cohort analysis of primigravida mothers who delivered via CS at the QEH between August 2022 and August 2024. The study population included singleton patients with neonates born at a gestation of greater than 28 weeks. All patient data was anonymized. Results: There were a total of 1273 primigravid patients over the two year study period, of these 348 delivered via CS, a rate of 27.3%. The most common indication for CS was fetal distress (32.6%), followed by failed induction/failed augmentation of labor (21.3%), and eclampsia/preeclampsia (7.8%). The majority of CS were emergency (90.8%), the remaining 9.2% elective. There was a very high number of patients who booked their pregnancy (99%). Most patients were in the 21–29-year age category (49.1%) and had full-term pregnancies (44.3%). Conclusion: In our institution, CS rates in primigravida women are high. Further audits should be undertaken to continuously evaluate the indications for CS with an overall aim to reduce the rates.
No takes yet. Share an insight, caveat, or question.
Murray et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: